JANX vs. USLM

In the year-to-date period, JANX achieves a -52.69% return, which is significantly lower than USLM's -22.46% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Janux Therapeutics, Inc. (JANX) and United States Lime & Minerals, Inc. (USLM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current JANX Sharpe Ratio is -0.61, which is lower than the USLM Sharpe Ratio of 0.91. The chart below compares the historical Sharpe Ratios of JANX and USLM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

JANX has not paid dividends to shareholders, while USLM's dividend yield for the trailing twelve months is around 0.20%.

The maximum JANX drawdown since its inception was -83.14%, which is greater than USLM's maximum drawdown of -77.09%. Use the drawdown chart below to compare losses from any high point for JANX and USLM. For additional features, visit the drawdowns tool.

Janux Therapeutics, Inc. (JANX) has a higher volatility of 21.83% compared to United States Lime & Minerals, Inc. (USLM) at 10.23%. This indicates that JANX's price experiences larger fluctuations and is considered to be riskier than USLM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Janux Therapeutics, Inc. and United States Lime & Minerals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.